General Information of Drug (ID: DMSI41E)

Drug Name
2-(2-hexylphenyl)isoindoline-1,3-dione
Synonyms CHEMBL245943; PP60; BDBM23841
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 307.4
Logarithm of the Partition Coefficient (xlogp) 5.4
Rotatable Bond Count (rotbonds) 6
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C20H21NO2
IUPAC Name
2-(2-hexylphenyl)isoindole-1,3-dione
Canonical SMILES
CCCCCCC1=CC=CC=C1N2C(=O)C3=CC=CC=C3C2=O
InChI
InChI=1S/C20H21NO2/c1-2-3-4-5-10-15-11-6-9-14-18(15)21-19(22)16-12-7-8-13-17(16)20(21)23/h6-9,11-14H,2-5,10H2,1H3
InChIKey
USXHUJLIZBGCGH-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
10638446
TTD ID
D0U4TN

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Oxysterols receptor LXR-alpha (NR1H3) TTECBXN NR1H3_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. Bioorg Med Chem. 2008 Apr 15;16(8):4272-85.